TYVYT Trademark

Trademark Overview


On Thursday, January 3, 2019, a trademark application was filed for TYVYT with the United States Patent and Trademark Office. The USPTO has given the TYVYT trademark a serial number of 79253564. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by Innovent Biologics (Suzhou) Co., Ltd.. The TYVYT trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceutical preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; vaccines; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; biologic...
tyvyt

General Information


Serial Number79253564
Word MarkTYVYT
Filing DateThursday, January 3, 2019
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5934673
Registration DateTuesday, December 17, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements


Goods and ServicesMedicines for human purposes used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceutical preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; vaccines; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; biological preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; antibiotics; diagnostic preparations for medical purposes; dietetic foods adapted for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSuzhou City 21
CN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSuzhou City 21
CN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSuzhou City 21
CN

Trademark Events


Event DateEvent Description
Friday, July 30, 2021CHANGE OF OWNER RECEIVED FROM IB
Friday, April 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 28, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 28, 2020FINAL DISPOSITION PROCESSED
Tuesday, March 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, October 5, 2019NOTIFICATION PROCESSED BY IB
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 29, 2019ASSIGNED TO LIE
Friday, August 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2019REFUSAL PROCESSED BY IB
Wednesday, April 3, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 3, 2019REFUSAL PROCESSED BY MPU
Friday, March 22, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 21, 2019NON-FINAL ACTION WRITTEN
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Friday, March 15, 2019APPLICATION FILING RECEIPT MAILED
Monday, March 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB